Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Journal of the European Academy of Dermatology and Venereology : JEADV|August 11, 2017
Recommendations for the management of comorbidity in hidradenitis suppurativaE Dauden, P Lazaro, M D Aguilar, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|October 5, 2015
Patient-relevant needs and treatment goals in nail psoriasisC Blome, A Costanzo, E Dauden, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|July 12, 2018
Position statement for the management of comorbidities in psoriasisE Dauden, A J Blasco, C Bonanad, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|May 20, 2020
Secukinumab treatment leads to normalization of quality of life and disease symptoms in psoriasis patients with or without prior systemic psoriasis therapy: the PROSE study resultsM Augustin, E Dauden, U Mrowietz, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|April 23, 2022
Tildrakizumab efficacy and safety in patients with psoriasis and concomitant metabolic syndrome: post hoc analysis of 5-year data from reSURFACE 1 and reSURFACE 2A P Fernandez, E Dauden, S Gerdes, et al.
The Pharmacogenomics Journal|November 19, 2014
Association of the PDE3A-SLCO1C1 locus with the response to anti-TNF agents in psoriasisA Julià, C Ferrándiz, E Dauden, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 5, 2014
Safety of classic and biologic systemic therapies for the treatment of psoriasis in elderly: an observational study from national BIOBADADERM registryC Medina, G Carretero, C Ferrandiz, et al.
Pageof 3